Dual-Acting Peripherally Restricted Delta/Kappa Opioid (CAV1001) Produces Antinociception in Animal Models of Sub-Acute and Chronic Pain

References

• Totsch SK, Sorge RE. Immune system involvement in specific pain conditions. Mol Pain. 2017;13:1–17.
   Web of Science ®Google Scholar
• Stein C, Clark JD, Oh U, et al. Peripheral mechanisms of pain and analgesia. Brain Res Rev. 2009;60:90–113.
   PubMedGoogle Scholar
• Morlion B, Coluzzi F, Aldington D, et al. Pain chronification: what should a non-pain medicine specialist know? Curr Med Res Opin. 2018;34(7):1169–1178.
   PubMed Web of Science ®Google Scholar
• Barry DT, Marshall BDL, Becker WC, et al. Duration of opioid prescriptions predicts incident nonmedical use of prescription opioids among U.S. veterans receiving medical care. Drug Alcohol Depend. 2018;191:348–354.
   PubMed Web of Science ®Google Scholar
• Merighi S, Gessi S, Varani K, et al. Morphine mediates a proinflammatory phenotype via μ-opioid receptor-PKCɛ-Akt-ERK1/2 signaling pathway in activated microglial cells. Biochem Pharmacol. 2013;86(4):487–496.
   PubMed Web of Science ®Google Scholar
• McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2013;2013(8):CD006146.
   Google Scholar
• Knezevic NN, Yekkirala A, Yaksh TL. Basic/translational development of forthcoming opioid- and nonopioid-targeted pain therapeutics. Anesth Analg. 2017;125(5):1714–1732.
   Web of Science ®Google Scholar
• Bee LA, Bannister K, Rahman W, Dickenson AH. Mu-opioid and noradrenergic α(2)-adrenoceptor contributions to the effects of tapentadol on spinal electrophysiological measures of nociception in nerve-injured rats. Pain. 2011;152(1):131–139.
   PubMed Web of Science ®Google Scholar
• Wallace MS, Moulin D, Clark AJ, et al. A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008–a long-acting, parenteral opioid analgesic–in the treatment of postherpetic neuralgia. J Opioid Manag. 2006;2(3):167–173.
   PubMedGoogle Scholar
• Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett. 2004;361:184–187.
   PubMed Web of Science ®Google Scholar
• Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137–188.
   PubMed Web of Science ®Google Scholar
• Yamamoto J, Kawamata T, Niiyama Y, Omote K, Namiki A. Down-regulation of mu opioid receptor expression within distinct subpopulations of dorsal root ganglion neurons in a murine model of bone cancer pain. Neuroscience. 2008;151(3):843–853.
   Web of Science ®Google Scholar
• Corder G, Castro DC, Bruchas MR, Scherrer G. Endogenous and exogenous opioids in pain. Annu Rev Neurosci. 2018;41:453–473.
   PubMed Web of Science ®Google Scholar
• Banghart MR, Sabatini BL. Photoactivatable neuropeptides for spatiotemporally precise delivery of opioids in neural tissue. Neuron. 2012;73:249–259.
   Web of Science ®Google Scholar
• Mansour A, Fox CA, Burke S, et al. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol. 1994;350:412–438.
   PubMed Web of Science ®Google Scholar
• Gendron L, Mittal N, Beaudry H, Walwyn W. Recent advances on the δ opioid receptor: from trafficking to function. Br J Pharmacol. 2015;172:403–419.
   Web of Science ®Google Scholar
• Chen S-R, Pan H-L. Removing TRPV1-expressing primary afferent neurons potentiates the spinal analgesic effect of δ-opioid agonists on mechano-nociception. Neuropharmacology. 2008;55(2):215–222.
   Web of Science ®Google Scholar
• Berg KA, Rowan MP, Gupta A, et al. Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons. Mol Pharmacol. 2012;81:264–272.
   PubMed Web of Science ®Google Scholar
• Puehler W, Zollner C, Brack A, et al. Rapid upregulation of the mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience. 2004;129(2):473–479.
   Web of Science ®Google Scholar
• Mousa SA, Cheppudira BP, Shaqura M, et al. Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain. 2007;130:502–513.
   PubMed Web of Science ®Google Scholar
• Ni J, Gao Y, Gong S, Guo S, Hisamitsu T, Jiang X. Regulation of μ-opioid type 1 receptors by microRNA134 in dorsal root ganglion neurons following peripheral inflammation. Eur J Pain. 2013;17(3):313–323.
   Web of Science ®Google Scholar
• Celik MO, Labuz D, Henning K, et al. Leukocyte opioid receptors mediate analgesia via Ca(2+)-regulated release of opioid peptides. Brain Behav Immun. 2016;57:227–242.
   PubMed Web of Science ®Google Scholar
• Riviere PJM. Peripheral kappa-opioid agonists for visceral pain. Br J Pharmacol. 2004;141:1331–1334.
   PubMed Web of Science ®Google Scholar
• Brackley AD, Gomez R, Akopian AN, Henry MA, Jeske NA. GRK2 constitutively governs peripheral delta opioid receptor activity. Cell Rep. 2016;16(10):2686–2698.
   Web of Science ®Google Scholar
• Eans SO, Ganno ML, Mizrachi E, et al. Parallel synthesis of hexahydrodiimidazodiazepines heterocyclic peptidomimetics and their in vitro and in vivo activities at mu (MOR), delta (DOR), and kappa (KOR) opioid receptors. J Med Chem. 2015;58:4905–4917.
   Web of Science ®Google Scholar
• Yoon MH, Yaksh TL. Evaluation of interaction between gabapentin and ibuprofen in the formalin test in rats. Anesthesiology. 1999;91(4):1006–1013.
   Web of Science ®Google Scholar
• Soelberg CD, Brown RE, Du Vivier D, Meyer JE, Ramachandran BK. The US opioid crisis: current federal and state legal issues. Anesth Analg. 2017;125(5):1675–1681.
   PubMed Web of Science ®Google Scholar
• Ostling PS, Davidson KS, Anyama BO, et al. America’s opioid epidemic: a comprehensive review and look into the rising crisis. Curr Pain Headache Rep. 2018;22(5):32.
   PubMed Web of Science ®Google Scholar
• Petho G, Reeh PW. Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors. Physiol Rev. 2012;92:1699–1775.
   PubMed Web of Science ®Google Scholar
• George J, Pulickal SJ, Singh A, et al. Locally mediated analgesic effect of bradykinin type 2 receptor antagonist HOE 140 during acute inflammatory pain in rats. J Burn Care Res. 2014;35(6):e391–8.
   Web of Science ®Google Scholar
• Parada CA, Tambeli CH, Cunha FQ, Ferreira SH. The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience. 2001;102(4):937–944.
   Web of Science ®Google Scholar
• Jiang Y-L, He X-F, Shen Y-F, et al. Analgesic roles of peripheral intrinsic met-enkephalin and dynorphin A in long-lasting inflammatory pain induced by complete Freund’s adjuvant in rats. Exp Ther Med. 2015;9:2344–2348.
   Web of Science ®Google Scholar
• Hawkins P, Armstrong R, Boden T, et al. Applying refinement to the use of mice and rats in rheumatoid arthritis research. Inflammopharmacol. 2015;23:131–150.
   PubMed Web of Science ®Google Scholar
• Zhu X, Eisenach JC. Cyclooxygenase-1 in the spinal cord is altered after peripheral nerve injury. Anesthesiology. 2003;99(5):1175–1179.
   Web of Science ®Google Scholar
• Sosanya NM, Kumar R, Clifford JL, et al. Identifying plasma derived extracellular vesicle (EV) contained biomarkers in the development of chronic neuropathic pain. J Pain. 2020;21(1–2):82–96.
   Web of Science ®Google Scholar
• Austin PJ, Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokine. J Neuroimmunol. 2010;229:26–50.
   PubMed Web of Science ®Google Scholar
• Mika J, Popiolek-Barczyk K, Rojewska E. Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain. PLoS One. 2014;9(8):e104420.
   Web of Science ®Google Scholar
• Schroder W, Vry JD, Tzschentke TM. Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rats models of nociceptive and neuropathic pain. Eur J Pain. 2010;14(8):814–821.
   PubMed Web of Science ®Google Scholar
• Hartrick CT. Noradrenergic reuptake inhibition in the treatment of pain. Expert Opin Investig Drugs. 2012;21(12):1827–1834.
   PubMed Web of Science ®Google Scholar
• Tanabe M, Takasu K, Takeuchi Y, Ono H. Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury. J Neurosci Res. 2008;86(15):3258–3264.
   Web of Science ®Google Scholar
• Mantyh P. Bone cancer pain: from mechanism to therapy. Curr Opin Support Palliat Care. 2014;8(2):83–90.
   PubMed Web of Science ®Google Scholar
• Habtezion A. Inflammation in acute and chronic pancreatitis. Curr Opin Gastroenterol. 2015;31(5):395–399.
   PubMed Web of Science ®Google Scholar
• Craft RM, Henley SR, Haaseth RC, Hruby VJ, Porreca F. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. J Pharmacol Exp Ther. 1995;275(3):1535–1542.
   PubMed Web of Science ®Google Scholar
• Kannampalli P, Sengupta JN. Role of principal inotropic and metabotropic receptors in visceral pain. J Neurogastroenterol Motil. 2015;21(2):147–158.
   Web of Science ®Google Scholar
• Mangel AW, Bornstein JD, Hamm LR, et al. Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2008;28(2):239–249.
   PubMed Web of Science ®Google Scholar
• Sengupta JN, Snider A, Su X, Gebhart GF. Effects of kappa opioids in the inflamed rat colon. Pain. 1999;79(2–3):175–185.
   Web of Science ®Google Scholar
• Fowler M, Clifford JL, Garza TH, et al. A rat model of full thickness thermal injury characterized by thermal hyperalgesia, mechanical allodynia, pronociceptive peptide release and tramadol analgesia. Burns. 2014;40:759–771.
   Web of Science ®Google Scholar
• Mastrangelo F, Frydas I, Ronconi G, et al. Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37. J Biol Regul Homeost Agents. 2018;32(2):195–198.
   PubMed Web of Science ®Google Scholar
• Salemi S, Aeschlimann A, Wollina U, et al. Up-regulation of delta-opioid receptors and kappa-opioid receptors in the skin of fibromyalgia patients. Arthritis Rheum. 2007;56(7):2464–2466.
   Web of Science ®Google Scholar